Granite Point Capital
Late Stage Β· 1 people tracked
Find your way into Granite Point Capital
1 people in our graph share verified history with the Granite Point Capital team β schools, employers, funds. One of them is your warm intro.
Team Β· 1 people
from public directoriesWhat they invest in
from 3 of 4 portfolio companiesBiotech Γ2AdTech Γ1AI & Machine Learning Γ1E-commerce Γ1Healthtech Γ1Retail Tech Γ1
HQs:United StatesΓ4
Investments Β· 4 tracked
founders shown can be your intro pathBy year:2021 Β· 12020 Β· 12 dated
Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.
BiotechHealthtechMendham, US
Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)
BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)
Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalPontifax Venture CapitalAmzak HealthDelos Capital+8 more
Teikametrics offers an AI-powered marketplace intelligence platform for brands selling on Amazon, Walmart, and TikTok Shop, covering multi-marketplace campaign management, full-funnel advertising, generative-AI listing optimization, and analytics.
AdTechAI & Machine LearningE-commerceRetail TechBoston, US
Alasdair McLean-Foreman(Executive Officer, Director, Promoter)inSrinivas Guddanti(Executive Officer)Michael McMahon(Director)John Traugott(Director)Austin Westerling(Director)
Co-investorsCentana Growth PartnersIntel CapitalProgress VenturesJump Capital
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesTeikametrics Β· startupfundraising.com Β· Jun 17, 2026
Public market activity Β· per SEC filings
what is this? βDisclosed stake Β· filed May 2017
Disclosed stake Β· filed Feb 2016
Disclosed stake Β· filed Aug 2015
Disclosed stake Β· filed Feb 2015
9 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings β stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- What stage does Granite Point Capital invest at?
- Granite Point Capital invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.